SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Opiant Pharmaceuticals Inc. (Nasdaq – OPNT) BALA CYNWYD – November 14, 2022 /Newsfile/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Opiant Pharmaceuticals Inc. (“Opiant” or the “Company”) (Nasdaq – OPNT) for possible breaches … Continue reading Opiant Pharmaceuticals Inc. (Nasdaq – OPNT)